Jump to Main-Site Navigation
UCERIS™ (budesonide) extended release tablets for the induction of remission in active, mild to moderate ulcerative colitis. UCERIS contains budesonide, a locally acting corticosteroid, in a novel oral tablet formulation that utilizes proprietary MMX® multi-matrix system colonic delivery technology.For full prescribing and safety information for Uceris, click here
(omeprazole/sodium bicarbonate) is an immediate-release oral proton pump inhibitor (PPI) used in adults to treat heartburn and other symptoms that happen with gastroesophageal reflex disease (GERD). For Full prescribing and safety information for Zegerid, click here
is promoted by MSD Consumer Products, Inc., a subsidiary of Merck & Co., Inc. GlaxoSmithKline and Norgine have rights to ZEGERID in certain territories outside the U.S.
(metformin hydrochloride extended release tablets) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. As with all metformin products, GLUMETZA has a boxed warning for lactic acidosis. For Full prescribing and safety information for GLUMETZA, including a Black Box warning, click here
(bromocriptine mesylate) is a first-in-class antidiabetic treatment that may lower your blood sugar, without increasing insulin. For Full prescribing and safety information for Cycloset, click here
is a fenofibrate prescribed to treat adults with hyperlipidemia (high cholesterol in the blood), mixed dyslipidemia (a combination of high Low-density lipoprotein (LDL) cholesterol, high triglycerides, and low High-density lipoprotein (HDL) cholesterol), or hypertriglyceridemia (high triglyceride levels in the blood) in combination with eating a healthy diet low in saturated fat and cholesterol. For Full prescribing and safety information for Fenoglide, click here
Back to Top
Product Adverse Events or Product Complaints:
Monday - Friday, 9:00am - 7:00pm Eastern Time
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Jump to Content
Page 'Breadcrumb' Navigation:
Jump to Content